Nasacort Aq 15 Mcg/Dose Nasal Spray

Brand : sanofi-aventis pakistan ltd.

Rs. 909.38

Rs. 957.25

|

QUICK DELIVERY

SPECIFICATION

Requires Prescription (YES/NO)

Yes

Generics

Triamcinolone Acetonide

Used For

Nasal Congestion

How it works

Triamcinolone acetonide is a more potent derivative of triamcinolone and is approximately 8 times more potent than prednisone. Although the precise mechanism of corticosteroid antiallergic action is unknown, corticosteroids are very effective in the treatment of allergic diseases in man.

USAGE AND SAFETY

Dosage

Triamcinolone Acetonide

Side Effects

Headache , nasal irritation , dry mucous membranes , naso-sinus congestion, throat discomfort , sneezing and epistaxis.

Drug Interactions

Some medicines may increase the effects and your doctor may wish to monitor you carefully if you are taking these medicines (including some medicines for HIV: ritonavir, cobicistat) .

Indication

It is given as a spray in the nose to treat the nasal symptoms of allergic rhinitis.

When not to Use

Do not use if: You are allergic (hypersensitive) to triamcinolone acetonide or any of the other ingredients. Signs of an allergic reaction include: a rash (hives), itching, swallowing or breathing problems, swelling of your lips, face, throat or tongue.

PRECAUTIONS

Precaution

If there is any reason to suppose that adrenal function is impaired, care must be taken while transferring patients from systemic steroid treatment to this spray.

WARNINGS

Warning 1

In clinical studies , it is administered intranasally, the development of localised infections of the nose and pharynx with Candida albicans has rarely occurred. When such an infection develops it may require treatment with appropriate local therapy and temporary discontinuation of treatment with this medicine.

Warning 2

Because of the inhibitory effect of corticosteroids on wound healing in patients who have experienced recent nasal septal ulcers, nasal surgery or trauma, it should be used with caution until healing has occurred.

Warning 3

Glaucoma and/or cataracts have been reported in patients receiving nasal corticosteroids. Therefore, close monitoring is warranted in patients with a change in vision or with a history of increased intraocular pressure, glaucoma and/or cataracts.